LIP
EW icon

Liontrust Investment Partners’s Edwards Lifesciences EW Stock Holding History

Liontrust Investment Partners’s Portfolio EW Stock Details EW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$91.2M Sell
1,138,371
-106,010
-9% -$8.74M 1.56% 25
2025
Q4 		$106M Sell
1,244,381
-115,780
-9% -$9.5M 1.57% 18
2025
Q3 		$106M Sell
1,360,161
-72,348
-5% -$5.65M 1.55% 26
2025
Q2 		$112M Sell
1,432,509
-85,643
-6% -$6.39M 1.6% 28
2025
Q1 		$110M Sell
1,518,152
-92,287
-6% -$6.61M 1.72% 23
2024
Q4 		$119M Buy
1,610,439
+402,261
+33% +$28.2M 1.73% 23
2024
Q3 		$112M Hold
1,208,178
– – 1.59% 25
2024
Q2 		$112M Sell
1,208,178
-26,957
-2% -$2.39M 1.59% 25
2024
Q1 		$118M Sell
1,235,135
-41,571
-3% -$3.49M 1.65% 28
2023
Q4 		$97.3M Buy
1,276,706
+1,258,056
+6,746% +$87.5M 1.41% 29
2023
Q3 		$1.29M Buy
+18,650
New +$1.5M 0.02% 156

Other funds holding EW

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

Liontrust Investment Partners's EW Position: Q1 2026 in Review

Liontrust Investment Partners reduced its Edwards Lifesciences (EW) stake by 8.5% in Q1 2026, selling an estimated $8.74M and leaving 1,138,371 shares worth $91.2M. The position accounts for 1.56% of the portfolio, ranked #25.

Liontrust Investment Partners first reported a position in EW in Q3 2023 and has held it in 11 quarters since. The position peaked at $119M in Q4 2024. 1,283 funds tracked by Wall St. Rank hold EW as of Q1 2026.

  • Liontrust Investment Partners held 1,138,371 shares of Edwards Lifesciences worth $91.2M as of Q1 2026.
  • Liontrust Investment Partners sold 106,010 Edwards Lifesciences shares in Q1 2026, an estimated $8.74M.
  • Edwards Lifesciences made up 1.56% of Liontrust Investment Partners's portfolio in Q1 2026, its #25 holding.
  • Liontrust Investment Partners first reported a position in Edwards Lifesciences in Q3 2023 and has held it in 11 quarters since.
  • Liontrust Investment Partners's Edwards Lifesciences position peaked at $119M in Q4 2024.
  • 1,283 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q1 2026.

Based on Liontrust Investment Partners's 13F filing for Q1 2026, filed 13 May 2026.